Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Enhanced Bioavailability And Anthelmintic Efficacy Of Mebendazole In Redispersible Microparticles With Low-substituted Hydroxypropylcellulose

P. M. de la Torre-Iglesias, J. García-Rodríguez, G. Torrado, S. Torrado, S. Torrado-Santiago, F. Bolás-Fernández
Published 2014 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background Mebendazole (MBZ) is an extremely insoluble and therefore poorly absorbed drug and the variable clinical results may correlate with blood concentrations. The necessity of a prolonged high dose treatment of this drug increases the risk of adverse effects. Methods In the present study we prepared redispersible microparticles (RDM) containing MBZ, an oral, poorly water-soluble drug, in different proportions of low-substituted hydroxypropylcellulose (L-HPC). We investigated the microparticulate structures that emerge spontaneously upon dispersion of an RDM in aqueous medium and elucidated their influence on dissolution, and also on their oral bioavailability and therapeutic efficiency using a murine model of infection with the nematode parasite Trichinella spiralis. Results Elevated percentages of dissolved drug were obtained with RDM at 1:2.5 and 1:5 ratios of MBZ: L-HPC. Thermal analysis showed an amorphization of MBZ in the RDM by the absence of a clear MBZ melting peak in formulations. The rapid dissolution behavior could be due to the decreased drug crystallinity, the fast dissolution time of carriers as L-HPC, together with its superior dispersibility and excellent wetting properties. RDM-1:2.5 and RDM-1:5 resulted in increased maximum plasma concentration and area(s) under the curve (AUC)0-∞ values. Likewise, after oral administration of the RDM-1:2.5 and RDM-1:5 the AUC0-∞ were 2.67- and 2.97-fold higher, respectively, compared to those of pure MBZ. Therapeutic activity, assessed on the Trichinella spiralis life cycle, showed that RDM-1:5 was the most effective in reducing the number of parasites (4.56-fold) as compared to pure MBZ, on the encysted stage. Conclusion The MBZ: L-HPC RDM might be an effective way of improving oral bioavailability and therapeutic activity using low doses of MBZ (5 mg/kg), which implies a low degree of toxicity for humans.
This paper references
10.1016/J.EJPB.2006.11.020
Investigation of the release mechanism of a sparingly water-soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions.
E. Karavas (2007)
Drug Design, Development and Therapy Enhanced bioavailability and anthelmintic efficacy of mebendazole
Development of chitosanbased nanoparticles through inter-polymeric complexation for oral drug delivery
S Jana (2013)
10.1016/J.IJPHARM.2003.11.030
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
K. Daniel-Mwambete (2004)
10.1016/j.ijpharm.2010.10.002
Changed crystallinity of mebendazole solid dispersion: improved anthelmintic activity.
J. García-Rodríguez (2011)
10.1016/j.jpba.2008.11.002
Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems.
M. Cirri (2009)
10.1017/S0031182000049507
Accelerated expulsion of adult Trichinella spiralis in mice given lymphoid cells and serum from infected donors.
D. Wakelin (1976)
10.1128/AAC.30.6.953
Comparative efficacy of ketoconazole and mebendazole in experimental trichinosis.
J. A. Hess (1986)
10.1017/S0022149X0928936X
Alveolar and cystic echinococcosis: towards novel chemotherapeutical treatment options.
A. Hemphill (2009)
10.1016/j.jpba.2008.11.003
Physical-chemical characterization of binary and ternary systems of ketoprofen with cyclodextrins and phospholipids.
M. Cirri (2009)
10.1016/S0188-0128(99)00054-8
Evaluation of albendazole prodrugs in experimental trichinellosis.
L. Yépez-Mulia (1999)
10.1016/j.carbpol.2013.12.047
Valsartan inclusion by methyl-β-cyclodextrin: thermodynamics, molecular modelling, Tween 80 effect and evaluation.
R. Chadha (2014)
10.1016/j.ejpb.2008.06.010
Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
A. N. Usha (2008)
In vitro and in vivo evaluation of a sublingual fentanyl water formulation
SC Lim (2013)
10.1016/j.ejps.2009.12.009
Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.
Y. Kawabata (2010)
10.1007/s10973-011-1299-x
Application of DSC, IST, and FTIR study in the compatibility testing of nateglinide with different pharmaceutical excipients
N. R. Pani (2011)
10.1016/j.ijpharm.2012.11.044
Formulation and drying of miconazole and itraconazole nanosuspensions.
Ana M Cerdeira (2013)
10.1016/j.actatropica.2013.03.006
Benznidazole prevents endothelial damage in an experimental model of Chagas disease.
A. Molina-Berríos (2013)
10.1016/S0001-706X(03)00031-7
Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics.
A. D. Dayan (2003)
10.1016/j.ejpb.2013.09.007
Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.
Chau Le-Ngoc Vo (2013)
10.1016/0378-5173(94)00374-E
Utilization of differential scanning calorimetry as a screening technique to determine the compatibility of ketoprofen with excipients
P. Mura (1995)
Mebendazol: identificacao das formas polimorficas em diferntes materias-primas e medicamentos (referencia e genericos) disponiveis no mercado nacional
Pedro Eduardo Fröehlich (2005)
10.1016/j.ijpharm.2010.12.019
Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
P. Karmwar (2011)
10.1016/j.ejpb.2012.09.016
Development of an oral solid dispersion formulation for use in low-dose metronomic chemotherapy of paclitaxel.
J. Moes (2013)
10.1016/J.POWTEC.2014.01.089
Hydrophilic polymer solubilization on norfloxacin solubility in preparation of solid dispersion
G. K. Loh (2014)
10.1016/j.vetpar.2013.01.054
Analysis of the effect of a 2-(trifluoromethyl)-1H-benzimidazole derivative on Trichinella spiralis muscle larvae.
Félix Matadamas-Martínez (2013)
10.1017/S0022149X00011172
Comparative efficacy of flubendazole and mebendazole on encysted larvae of Trichinella spiralis (USA strain) in the diaphragm of mice and rats.
J. Maki (1988)
10.1016/j.ijpharm.2010.08.007
Improved dissolution and pharmacokinetic behavior of cyclosporine A using high-energy amorphous solid dispersion approach.
S. Onoue (2010)
10.1016/j.ejpb.2012.06.016
Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
Meimei Zhang (2012)
10.1016/j.carbpol.2013.06.064
Development of chitosan-based nanoparticles through inter-polymeric complexation for oral drug delivery.
Sougata Jana (2013)
10.1016/S0939-6411(03)00004-3
Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs.
E. Swanepoel (2003)
10.1016/S0928-0987(00)00084-1
Physicochemical characterization of solid dispersions of the antiviral agent UC-781 with polyethylene glycol 6000 and Gelucire 44/14.
F. Damian (2000)
10.1016/J.JPBA.2005.01.025
Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole.
M. D. de Villiers (2005)
Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrinphosphatidylcholine ternary Systems
M Cirri (2009)
10.1016/S0378-5173(97)00204-4
A novel formulation of albendazole solution: oral bioavailability and efficacy evaluation
S. Torrado (1997)
A case from India of neurocysticercosis responsive to albendazole treatment.
E. Zardi (2000)
10.1016/j.ejpb.2012.04.019
Dry powder insufflation of crystalline and amorphous voriconazole formulations produced by thin film freezing to mice.
Nicole A Beinborn (2012)
Study of the reproductive capacity of Trichinella spiralis recovered from experimentally infected mice under-dosed with albendazole or mebendazole.
J. Delarosa (2007)
10.1016/j.ijpharm.2011.12.001
Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Lucas Sievens-Figueroa (2012)
10.1016/S0168-3659(02)00483-2
Pharmacokinetic evaluation of guar gum-based colon-targeted drug delivery systems of mebendazole in healthy volunteers.
Y. Krishnaiah (2003)
Enhanced bioavailability and anthelmintic efficacy of mebendazole
10.2147/DDDT.S42619
In vitro and in vivo evaluation of a sublingual fentanyl wafer formulation
S. C. Lim (2013)
10.1016/j.ejpb.2010.01.011
Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats.
W. Yang (2010)
10.1016/j.ejpb.2009.09.007
Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
James C Dinunzio (2010)
10.1016/J.EJPB.2004.05.005
Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
P. Mura (2005)
10.1016/S0378-5173(02)00559-8
Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
J. García (2003)



This paper is referenced by
10.1080/10837450.2017.1363775
Understanding the compaction behaviour of low-substituted HPC: macro, micro, and nano-metric evaluations
Amr Elshaer (2018)
10.2147/DDDT.S87738
Improving dissolution and oral bioavailability of pranlukast hemihydrate by particle surface modification with surfactants and homogenization
Eun-sol Ha (2015)
10.1371/journal.pntd.0006422
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets
M. Siles-Lucas (2018)
10.36468/pharmaceutical-sciences.576
Enhancement of the Dissolution Rate of Indomethacin by Solid Dispersions in Low-substituted Hydroxypropyl Cellulose
Estefanía TASCÓN-OTERO (2019)
10.2147/DDDT.S86458
Design of a gelatin microparticle-containing self-microemulsifying formulation for enhanced oral bioavailability of dutasteride
I. Baek (2015)
10.1208/s12249-018-1057-5
Solving the Delivery Problems of Triclabendazole Using Cyclodextrins
D. Real (2018)
10.1016/j.ejps.2020.105582
Comparison of co-former performance in co-amorphous formulations: single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers.
Wenqi Wu (2020)
10.1007/s40336-016-0185-8
Imaging bacteria with radiolabelled quinolones, cephalosporins and siderophores for imaging infection: a systematic review
S. Auletta (2016)
10.2147/DDDT.S90706
Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process
Eun-sol Ha (2015)
Bioequivalence & Bioavailability
Yacobucci (2015)
10.4172/JBB.10000E68
Microparticles: A Novel Approach to Enhance Drug Bioavailability
Yacobucci Mj (2015)
10.1208/s12249-020-01805-x
Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment.
Julio Mena-Hernández (2020)
10.2174/1381612825666190130110653
Bioavailability enhancement of poorly soluble drugs: The holy grail in pharma industry.
Mamunur Rashid (2019)
Semantic Scholar Logo Some data provided by SemanticScholar